Biological activity of silylated amino acid containing substance P analogues

J Pept Res. 2004 Mar;63(3):290-6. doi: 10.1111/j.1399-3011.2004.00145.x.

Abstract

The need to replace natural amino acids in peptides with nonproteinogenic counterparts to obtain new medicinal agents has stimulated a great deal of innovation on synthetic methods. Here, we report the incorporation of non-natural silylated amino acids in substance P (SP), the binding affinity for the two hNK-1 binding sites and, the potency to stimulate phospholipase C (PLC) and adenylate cyclase of the resulting peptide. We also assess the improvement of their stability towards enzyme degradation. Altogether, we found that replacing glycine with silaproline (Sip) in position 9 of SP leads to a potent analogue exhibiting an increased resistance to angiotensin-converting enzyme hydrolysis.

MeSH terms

  • Adenylyl Cyclases / metabolism
  • Amino Acid Substitution
  • Animals
  • Binding Sites
  • Biological Assay
  • CHO Cells
  • Cricetinae
  • Glycine / chemistry
  • Organosilicon Compounds / chemistry*
  • Organosilicon Compounds / metabolism
  • Organosilicon Compounds / pharmacology*
  • Peptidyl-Dipeptidase A / metabolism
  • Proline / analogs & derivatives*
  • Proline / chemistry
  • Receptors, Neurokinin-1 / agonists
  • Receptors, Neurokinin-1 / metabolism
  • Substance P / analogs & derivatives*
  • Substance P / chemical synthesis
  • Substance P / metabolism
  • Trimethylsilyl Compounds / chemistry
  • Type C Phospholipases / metabolism

Substances

  • Organosilicon Compounds
  • Receptors, Neurokinin-1
  • Trimethylsilyl Compounds
  • silaproline
  • Substance P
  • Proline
  • Type C Phospholipases
  • Peptidyl-Dipeptidase A
  • Adenylyl Cyclases
  • Glycine